subject area of
- A case of refractory Sézary syndrome with large-cell transformation responsive to brentuximab vedotin. Journal Articles
- Survival Outcomes for US and Canadian Patients Diagnosed with Hodgkin Lymphoma before and after Brentuximab Vedotin Approval for Relapsed/Refractory Disease: A Retrospective Cohort Study Journal Articles